Night-Time pill could tame ADHD all day long
NCT ID NCT06577779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests Jornay PM, a once-daily ADHD pill taken at night, in 30 adults aged 18-60. The goal is to see if it improves focus, emotional control, and daily function from morning through early evening. Researchers will measure symptom changes over 10 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle massage at bedtime help kids with ADHD sleep?
- Do weighted blankets unlock better sleep for kids with ADHD?
- Smartphone app may boost parenting skills for child outbursts
- Can a Once-Daily pill tame ADHD and emotional storms?
- Could a phone app help parents of kids with special needs thrive?
- Could a Self-Help guide transform parenting stress for families of kids with NDD?